TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.

Jaishri O Blakeley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.